SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-16-004266
Filing Date
2016-01-06
Accepted
2016-01-06 06:00:11
Documents
1
Period of Report
2016-01-04

Document Format Files

Seq Description Document Type Size
1 form4-01062016_060101.html 4  
1 form4-01062016_060101.xml 4 4237
  Complete submission text file 0001415889-16-004266.txt   5661
Mailing Address 38 ANGELL BROOK DRIVE WEST BOYLSTON MA 01853
Business Address
ESBER HENRY JEMIL (Reporting) CIK: 0001391501 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-52991 | Film No.: 161325274

Mailing Address 4275 EXECUTIVE SQUARE, SUITE 200 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE, SUITE 200 LA JOLLA CA 92037 858-964-5123
INNOVUS PHARMACEUTICALS, INC. (Issuer) CIK: 0001411879 (see all company filings)

IRS No.: 870324697 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations